Key Events This Week
07 Sep: New 52-week and all-time high at Rs.176.60
08 Sep: New 52-week and all-time high at Rs.179.20
09 Sep: New 52-week and all-time high at Rs.180.50
10 Sep: Price pullback to Rs.173.30 amid market weakness
11 Sep: Week closes at Rs.170.80, outperforming Sensex decline
Monday, 7 September: New 52-Week and All-Time Highs Signal Strong Start
Gujarat Kidney & Super Speciality Ltd began the week on a strong note, hitting a new 52-week high of Rs.176.60 and an all-time high of Rs.176. The stock gained 2.29% on the day, closing well above its key moving averages, signalling robust technical strength. This performance contrasted with the Sensex’s 0.46% decline to 36,218.97, highlighting the stock’s relative outperformance. The surge was supported by the company’s impressive quarterly results, including an 80.69% increase in operating profit and a 23.1% rise in profit before tax excluding other income, reaching Rs.6.27 crores. The MarketsMOJO upgrade to a Buy rating on 4 September further bolstered investor confidence.
Tuesday, 8 September: New Highs Amid Market Weakness and Slight Pullback
On 8 September, the stock touched a new 52-week and all-time high of Rs.179.20 despite a slight intraday decline of 0.76%, closing at Rs.175.25. The broader market remained weak, with the Sensex falling 0.21% to 36,144.32. Gujarat Kidney & Super Speciality Ltd’s ability to maintain levels above all key moving averages underscored its sustained strength. The day’s trading volume increased significantly, reflecting heightened investor interest. Technical indicators such as MACD and Bollinger Bands remained bullish, although the weekly RSI suggested some short-term caution.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Wednesday, 9 September: Fresh 52-Week High at Rs.180.50 Amid Strong Fundamentals
The stock continued its upward trajectory on 9 September, reaching a new 52-week high of Rs.180.50 and closing at Rs.176.75, up 0.86%. This marked the highest price level of the week and reflected strong buying interest despite the Sensex’s 0.62% decline to 35,921.77. The company’s robust quarterly financials, including record net sales of Rs.34.29 crores and highest quarterly PAT of Rs.5.18 crores, supported the rally. Technical momentum indicators such as MACD, Bollinger Bands, and Dow Theory remained bullish, reinforcing the positive trend. However, the weekly RSI continued to signal caution, suggesting potential short-term overbought conditions.
Thursday, 10 September: Market Weakness Triggers Price Pullback
On 10 September, Gujarat Kidney & Super Speciality Ltd experienced a pullback, closing at Rs.173.30, down 1.95%. This decline occurred amid a broadly weak market, with the Sensex marginally down 0.03% at 35,912.77. The stock’s retreat followed five consecutive days of gains, indicating a natural consolidation phase. Despite the pullback, the stock remained above key moving averages, maintaining its overall bullish technical posture. Volume was lower compared to earlier in the week, reflecting reduced trading activity during the correction.
Want to dive deeper on Gujarat Kidney & Super Speciality Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Friday, 11 September: Week Closes Slightly Lower but Outperforms Sensex
The week concluded with Gujarat Kidney & Super Speciality Ltd closing at Rs.170.80, down 1.44% on the day and 1.07% for the week. The Sensex declined 0.39% on the day and 1.68% for the week, underscoring the stock’s relative outperformance. Despite the weekly decline, the stock’s technical indicators remain predominantly bullish, supported by strong fundamentals and a recent upgrade to a Buy rating by MarketsMOJO. The company’s low debt-to-EBITDA ratio of 1.08 times and robust return on capital employed of 26.45% provide a solid financial foundation amid market volatility.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.176.60 | +2.29% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.175.25 | -0.76% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.176.75 | +0.86% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.173.30 | -1.95% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.170.80 | -1.44% | 35,773.24 | -0.39% |
Key Takeaways
Strong Relative Performance: Gujarat Kidney & Super Speciality Ltd outperformed the Sensex throughout the week, despite ending slightly lower, demonstrating resilience amid a weak broader market.
Multiple New Highs: The stock set new 52-week and all-time highs on three consecutive days (7, 8, and 9 September), reflecting strong investor interest and positive momentum.
Robust Financials: Record quarterly net sales of Rs.34.29 crores and an 80.69% increase in operating profit underpin the stock’s price strength and justify the recent upgrade to a Buy rating.
Technical Momentum: Bullish signals from MACD, Bollinger Bands, Dow Theory, and On-Balance Volume support the positive trend, although the weekly RSI suggests caution due to potential short-term overbought conditions.
Valuation and Institutional Interest: The stock trades at a premium valuation with a price-to-book ratio of 5.5 times and a P/E ratio near 88 times, while institutional holdings remain low, indicating cautious positioning by large investors.
Conclusion
Gujarat Kidney & Super Speciality Ltd’s week was characterised by strong price momentum, multiple new highs, and robust quarterly financial results that have driven a significant upgrade in market sentiment. While the stock closed the week slightly lower, it outperformed the broader Sensex, signalling relative strength in a challenging market environment. The company’s solid fundamentals, low leverage, and positive technical indicators provide a sound basis for its current valuation, although investors should remain mindful of the elevated price multiples and mixed short-term technical signals. Overall, Gujarat Kidney & Super Speciality Ltd remains a noteworthy micro-cap player in the hospital sector, demonstrating resilience and growth potential amid broader market volatility.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
